Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05498025 · ClinicalTrials.gov registry record · NA
The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT05498025 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 37 participants.
The verdict
NCT05498025, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
Background: There is scarce literature investigating how patients dispose of unused opioid supplies after their cesarean postoperative pain has faded. The Office of the Surgeon General has identified research on the prevention of opioid use disorder area as well as research on the management of pain as a "Surgeon General Priority" that needs urgent investigation. Hypothesis: At least 33% of postpartum women discharged home with an opioid prescription and a drug deactivation pouch will use the pouch to dispose of remaining opioids within 30 days of delivery. Methods: This is a prospective single arm interventional pilot study.
Interventions
- OTHER Deterra activated charcoal pouch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2023-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05498025
The ClinicalTrials.gov registry entry for NCT05498025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Deterra activated charcoal pouch is the first listed.
NCT05498025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05498025 about?
NCT05498025 is a clinical study titled "The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery". Background: There is scarce literature investigating how patients dispose of unused opioid supplies after their cesarean postoperative pain has faded. The Office of the Surgeon General has identified research on the prevention of opioid use disorder area as well as research on the management of pain...
What is the current status of trial NCT05498025?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2023-02-21. Estimated completion is 2023-07-29.
What interventions are being tested in trial NCT05498025?
The interventions under investigation include: Deterra activated charcoal pouch (OTHER).
Who is sponsoring clinical trial NCT05498025?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.